Company Vision
InnovaRadi Therapeutics Co. Ltd.: Born for the Moment, rooted in China and oriented toward the global market, InnovaRadi is deeply engaged in the field of radiopharmaceutical therapy. We focus on scientific innovation and clinical value to lead a new era of precision oncology.
Innovation Research
InnovaRadi's R&D system is guided by scientific and clinical value, focusing on unmet clinical needs. Our targeted alpha therapy (TAT) programs are expected to achieve efficient cancer cell eradication through precise targeting and local energy deposition, will provide patients with a brand-new treatment pathway.
News Center